Melatonin is a hormone that is produced from the pineal gland in a circadian pattern and plays a role in the initiation of sleep.

The production and release of this hormone is connected to the time of day, ideally increasing when it is dark and decreasing when it is light. Melatonin and cortisol follow opposite circadian patterns but are not cross-regulated in a negative feedback manner.

The production of melatonin decreases with age.

Treatment with melatonin may be useful in people with circadian rhythm sleep disorders, such as delayed sleep phase disorder, jet lag, shift worker disorder, and the non-24-hour sleep-wake disorder most commonly found in totally blind individuals.

Melatonin is not technically an adrenal or sex hormone however it is highly involved in the entire endocrine system. It is made in small amounts in the pineal gland in response to darkness and stimulated by Melanocyte Stimulating Hormone (MSH). 

Melatonin (1st Morning), a crucial marker of sleep-wake cycle regulation and overall well-being, is a key component of the ZRT Laboratory Urinary Neurotransmitters panel, highlighting its significance in both sleep medicine and general health monitoring. Melatonin, often referred to as the "sleep hormone," is produced by the pineal gland in the brain and plays a vital role in regulating the body's circadian rhythm. The measurement of first morning melatonin levels provides invaluable insights into an individual’s sleep quality and circadian rhythm health.

Melatonin (2nd Morning), a pivotal marker in the ZRT Laboratory Urinary Neurotransmitters panel, offers essential insights into an individual’s sleep-wake cycle and overall neuroendocrine health. This hormone, predominantly secreted by the pineal gland during darkness, is crucial for regulating circadian rhythms and promoting restful sleep. The measurement of melatonin levels on the second morning provides a unique perspective on the body's ability to maintain stable melatonin production across multiple sleep cycles.

Melatonin is not technically an adrenal or sex hormone however it is highly involved in the entire endocrine system. It is made in small amounts in the pineal gland in response to darkness and stimulated by Melanocyte Stimulating Hormone (MSH). 

Melatonin is not technically an adrenal or sex hormone however it is highly involved in the entire endocrine system. It is made in small amounts in the pineal gland in response to darkness and stimulated by Melanocyte Stimulating Hormone (MSH). 

Melatonin (Evening), a critical biomarker in the ZRT Laboratory Urinary Neurotransmitters panel, plays an instrumental role in assessing nocturnal melatonin production and understanding sleep-wake cycle disturbances in individuals. Melatonin, often called the 'darkness hormone', is naturally produced by the pineal gland in response to darkness, peaking during the night to regulate sleep patterns and circadian rhythms. The measurement of evening melatonin levels provides valuable insights into the body’s readiness for sleep and its ability to enter a restful state.

Melatonin (Night), a key indicator of sleep health and circadian rhythm, is a prominent marker in the ZRT Laboratory Urinary Neurotransmitters panel, underscoring its crucial role in evaluating nocturnal melatonin activity and overall well-being. Melatonin, known as the "sleep hormone," is produced by the pineal gland and is critical for regulating the sleep-wake cycle and maintaining the body's internal clock. Nighttime measurements of melatonin provide essential insights into an individual's natural sleep patterns and the effectiveness of their circadian rhythms.

Melatonin is not technically an adrenal or sex hormone however it is highly involved in the entire endocrine system. It is made in small amounts in the pineal gland in response to darkness and stimulated by Melanocyte Stimulating Hormone (MSH). 

Melatonin is not technically an adrenal or sex hormone however it is highly involved in the entire endocrine system. It is made in small amounts in the pineal gland in response to darkness and stimulated by Melanocyte Stimulating Hormone (MSH). A low MSH is associated with insomnia, an increased perception of pain, and mold exposure. Pineal melatonin (melatonin is also made in significant quantities in the gut) is associated with the circadian rhythm of all hormones (including female hormone release). It is also made in small amounts in the bone marrow, lymphocytes, epithelial cells and mast cells. Studies have shown that a urine sample collected upon waking has levels of 6-Hydroxymelatonin-sulfate (6-OHMS) that correlate well to the total levels of melatonin in blood samples taken continuously throughout the night. The DUTCH test uses the waking sample only to test levels of melatonin production. Low melatonin levels may be associated with insomnia, poor immune response, constipation, weight gain or increased appetite. Elevated melatonin is usually caused by ingestion of melatonin through melatonin supplementation or eating melatonin-containing foods. Elevated melatonin production that is problematic is rare, but levels can be higher in patients with Chronic Fatigue Syndrome and may be phase shifted (peaking later) in some forms of depression.

The urinary level of mercapturic acids indicates quantitatively the degree of activity or capability of phase II detoxification. Mercapturic acids are the final excretory products of detoxification and include a variety of functionalized xenobiotics that have been conjugated with glutathione or L-cysteine prior to excretion. When the rate of formation of functionalized xenobiotics (phase I) exceeds the capacity of phase II detoxification, more potent toxins accumulate.

Mercury intoxication is associated with a triad of symptoms: (1) mental changes, (2) spontaneous tremor and deficits in psychomotor performance, and (3) stomatitis and gingivitis. The toxic effects of mercury have been associated with neurological dysfunction, dementia, and autoimmune diseases. Although research suggests that the etiology of autism is multifactorial, numerous reports demonstrate that aspects of mercury toxicity appear similar to autism symptomatology.

According to the CDC, mercury released from amalgams may comprise up to 75% of an individual’s mercury exposure. Methylmercury from seafood is considered to be the most important source of non-occupational human mercury exposure. Blood mercury has revealed low level chronic and acute exposure from work environments. Significant exposure is evident when whole blood alkyl mercury is greater than 50 μg/L, or when inorganic mercury (Hg2+) exposure is greater than 200 μg/L. Children’s reference values for whole blood mercury from 1.5 to 1.0 μg/L have been proposed. Risk of Attention Deficit Hyperactivity Disorder (ADHD) was found to be nearly 10 times higher when blood mercury was above 29 nmol/L. The quantity of mercury assayed in blood and hair, but not urine, correlates with the severity of toxicity symptoms.

SOURCES:

Mercury (Hg) has three forms:

Elemental (metallic)- older glass thermometers, fluorescent light bulbs, dental amalgams, folk remedies, combustion, electrical industry (switches, batteries, thermostats), solvents, wood processing

Organic (methyl mercury)- seafood, thimerosal (preservative), fungicides

Inorganic- skin lightening compounds, industrial exposure, folk medicine, lamps, photography, disinfectants